DIN 02442167 — MOVANTIK 12.5 MG
MOVANTIK is a tablet of Naloxegol marketed by KNIGHT THERAPEUTICS INC.. The full Naloxegol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02442167
- Brand name
- MOVANTIK
- Active ingredient
- Naloxegol
- Strength
- 12.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- KNIGHT THERAPEUTICS INC.
- Health Canada status
- MARKETED
- Drug class
- Peripherally acting mu-opioid receptor antagonist (PAMORA)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Naloxegol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02442175 | MOVANTIK | 25 MG | TABLET | KNIGHT THERAPEUTICS INC. | MARKETED |